DNMT3B promoter polymorphisms and maternal risk of birth of a child with Down syndrome

Human Reproduction

Volumn 28, Issue 2, 2013, Pages 545-550

  Coppedè, Fabio ^a   Bosco, Paolo ^b   Tannorella, Pierpaola ^c   Romano, Carmelo ^b   Antonucci, Ivana ^d   Stuppia, Liborio ^d   Romano, Corrado ^b   Migliore, Lucia ^a,c  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b OASI RESEARCH INSTITUTE IRCCS   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

Author keywords

DNA methylation; DNA methyltransferase 3b; Down syndrome; maternal risk; polymorphisms

Indexed keywords

DNA METHYLTRANSFERASE 3B; HISTONE;

ADULT; ALLELE; ARTICLE; CENTROMERE; CHILDBIRTH; COHORT ANALYSIS; CONTROLLED STUDY; DNA METHYLATION; DOWN SYNDROME; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

EID: 84872530966     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/des376     Document Type: Article

References (36)

1. Antonarakis SE. Down syndrome. In: Jameson JL (ed). Principle of Molecular Medicine. Totowa, NJ: Humana Press, Inc, 1998, 1069-1078.
2. Bean LJ, Allen EG, Tinker SW, Hollis ND, Locke AE, Druschel C, Hobbs CA, O'Leary L, Romitti PA, Royle MHet al. Lack of maternal folic acid supplementation is associated with heart defects in Down syndrome: a report from the National Down Syndrome Project. Birth Defects Res A Clin Mol Teratol 2011;91: 885-893.
3. Bosco P, Guéant-Rodriguez RM, Anello G, Barone C, Namour F, Caraci F, Romano A, Romano C, Guéant JL. Methionine synthase (MTR) 2756 (A-.G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome. Am J Med Genet A 2003;121A: 219-224.
4. Brandalize AP, Bandinelli E, dos Santos PA, Roisenberg I, Schüler-Faccini L. Evaluation of C677T and A1298C polymorphisms of the MTHFR gene as maternal risk factors for Down syndrome and congenital heart defects. Am J Med Genet A 2009;149A: 2080-2087.
5. Brandalize AP, Bandinelli E, Dos Santos PA, Schüler-Faccini L. Maternal gene polymorphisms involved in folate metabolism as risk factors for Down syndrome offspring in Southern Brazil. Dis Markers 2010; 29: 95-101.
6. Chen Z, Zhou Z, Chen X, Xu J, Liu A, Du W, Gu D, Ge J, Guo Z, Wang X et al. Single nucleotide polymorphism in DNMT3B promoter and the risk for idiopathic thrombocytopenic purpura in Chinese population. J Clin Immunol 2008;28: 399-404.
7. Coppedè F. The complex relationship between folate/homocysteine metabolism and risk of Down syndrome. Mutat Res 2009;682: 54-70.
8. Coppedè F, Marini G, Bargagna S, Stuppia L, Minichilli F, Fontana I, Colognato R, Astrea G, Palka G, Migliore L. Folate gene polymorphisms and the risk of Down syndrome pregnancies in young Italian women. Am J Med Genet A 2006;140: 1083-1091.
9. Coppedè F, Colognato R, Bonelli A, Astrea G, Bargagna S, Siciliano G, Migliore L. Polymorphisms in folate and homocysteine metabolizing genes and chromosome damage in mothers of Down syndrome children. Am J Med Genet A 2007;143A: 2006-2015.
10. Coppedè F, Grossi E, Migheli F, Migliore L. Polymorphisms in folate-metabolizing genes, chromosome damage, and risk of Down syndrome in Italian women: identification of key factors using artificial neural networks. BMC Med Genomics 2010;3: 42.
11. Coppedè F, Zitarosa MT, Migheli F, Lo Gerfo A, Bagnoli S, Dardano A, Nacmias B, Mancuso M, Monzani F, Siciliano G et al. DNMT3B promoter polymorphisms and risk of late onset Alzheimer's disease. Curr Alzheimer Res 2012;9: 550-554.
12. Fonseca-Silva T, Oliveira MV, Fraga CA, Farias LC, Gomes EP, Barros LO, Roy A, Santiago Gomez R, Paula AM, Guimarães AL. DNMT3B (C46359T) polymorphisms and immunoexpression of DNMT3b and DNMT1 proteins in oral lichen planus. Pathobiology 2012;79: 18-23.
13. Gaunt TR, Rodríguez S, Day INM. Cubic exact solutions for the estimation of pairwise haplotype frequencies: implications for linkage disequilibrium analyses and a web tool 'CubeX'. BMC Bioinformatics 2007;8: 428.
14. Gopalakrishnan S, Sullivan BA, Trazzi S, Della Valle G, Robertson KD. DNMT3B interacts with constitutive centromere protein CENP-C to modulate DNA methylation and the histone code at centromeric regions. Hum Mol Genet 2009;18: 3178-3193.
15. Haggarty P, Hoad G, Harris SE, Starr JM, Fox HC, Deary IJ, Whalley LJ. Human intelligence and polymorphisms in the DNA methyltransferase genes involved in epigenetic marking. PLoS ONE 2010;5: e11329.
16. James SJ, Pogribna M, Pogribny IP, Melnyk S, Hine RJ, Gibson JB, Yi P, Tafoya DL, Swenson DH, Wilson VL et al. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 1999;70: 495-501.
17. Jung AY, Poole EM, Bigler J, Whitton J, Potter JD, Ulrich CM. DNA methyltransferase and alcohol dehydrogenase: gene-nutrient interactions in relation to risk of colorectal polyps. Cancer Epidemiol Biomarkers Prev 2008;17: 330-338.
18. Lamb NE, Freeman SB, Savage-Austin A, Pettay D, Taft L, Hersey J, Gu Y, Shen J, Saker D, May KM et al. Susceptible chiasmate configurations of chromosome 21 predispose to non-disjunction in both maternal meiosis I and meiosis II. Nat Genet 1996;14: 400-405.
19. Lee SJ, Jeon HS, Jang JS, Park SH, Lee GY, Lee BH, Kim CH, Kang YM, Lee WK, Kam S et al. DNMT3B polymorphisms and risk of primary lung cancer. Carcinogenesis 2005;26: 403-409.
20. Lejeune J, Gautier M, Turpin R. Etude des chromosomes somatiqaues de neuf enfants mongoliens. Compte Rendu d'Acad Sci 1959; 248: 1721-1722.
21. Leng S, Stidley CA, Bernauer AM, Picchi MA, Sheng X, Frasco MA, Van Den Berg D, Gilliland FD, Crowell RE, Belinsky SA. Haplotypes of DNMT1 and DNMT3B are associated with mutagen sensitivity induced by benzo[a]pyrene diol epoxide among smokers. Carcinogenesis 2008;29: 1380-1385.
22. Locke AE, Dooley KJ, Tinker SW, Cheong SY, Feingold E, Allen EG, Freeman SB, Torfs CP, Cua CL, Epstein MP et al. Variation in folate pathway genes contributes to risk of congenital heart defects among individuals with Down syndrome. Genet Epidemiol 2010; 34: 613-623.
23. Martínez-Frías ML, Pérez B, Desviat LR, Castro M, Leal F, Rodríguez L, Mansilla E, Martínez-Fernández ML, Bermejo E, Rodríguez-Pinilla E et al. Maternal polymorphisms 677C-T and 1298A-C of MTHFR, and 66A-G MTRR genes: is there any relationship between polymorphisms of the folate pathway, maternal homocysteine levels, and the risk for having a child with Down syndrome? Am J Med Genet A 2006;140: 987-997.
24. Melamed-Bessudo C, Levy AA. Deficiency in DNA methylation increases meiotic crossover rates in euchromatic but not in heterochromatic regions in Arabidopsis. Proc Natl Acad Sci USA 2012;109: E981-E988.
25. Mirouze M, Lieberman-Lazarovich M, Aversano R, Bucher E, Nicolet J, Reinders J, Paszkowski J. Loss of DNA methylation affects the recombination landscape in Arabidopsis. Proc Natl Acad Sci USA 2012; 109: 5880-5885.
26. Morris JK, Mutton DE, Alberman E. Revised estimates of the maternal age specific live birth prevalence of Down's syndrome. J Med Screen 2002; 9: 2-6.
27. Nam EJ, Kim KH, Han SW, Cho CM, Lee J, Park JY, Kang YM. The-283C/T polymorphism of the DNMT3B gene influences the progression of joint destruction in rheumatoid arthritis. Rheumatol Int 2010; 30: 1299-1303.
28. Perrella G, Consiglio MF, Aiese-Cigliano R, Cremona G, Sanchez-Moran E, Barra L, Errico A, Bressan RA, Franklin FC, Conicella C. Histone hyperacetylation affects meiotic recombination and chromosome segregation in Arabidopsis. Plant J 2010;62: 796-806.
29. Scala I, Granese B, Sellitto M, Salomè S, Sammartino A, Pepe A, Mastroiacovo P, Sebastio G, Andria G. Analysis of seven maternal polymorphisms of genes involved in homocysteine/folate metabolism and risk of Down syndrome offspring. Genet Med 2006;8: 409-416.
30. Shen H, Wang L, Spitz MR, Hong WK, Mao L, Wei Q. A novel polymorphism in human cytosine DNA-methyltransferase-3b promoter is associated with an increased risk of lung cancer. Cancer Res 2002;62: 4992-4995.
31. Stuppia L, Gatta V, Gaspari AR, Antonucci I, Morizio E, Calabrese G, Palka G. C677T mutation in the 5,10-MTHFR gene and risk of Down syndrome in Italy. Eur J Hum Genet 2002;10: 388-390.
32. Xiao Y, Word B, Hammons G, Lyn-Cook B. Transcriptional activity of DNMT3B in pancreatic cancer cells: effects of-149 (C-T) promoter polymorphism. Biochem Biophys Res Commun 2011;415: 220-223.
33. Zampieri BL, Biselli JM, Goloni-Bertollo EM, Vannucchi H, Carvalho VM, Cordeiro JA, Pavarino EC. Maternal risk for Down syndrome is modulated by genes involved in folate metabolism. Dis Markers 2012; 32: 73-81.
34. Zhang C, Fang Y, Xie B, Du YS, Cheng WH, Wang DX, Yu SY. Association of DNA methyltransferase 3B gene polymorphism with early-onset schizophrenia. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2010;27: 697-699.
35. Zhao H, Du W, Gu D, Wang D, Xue F, Ge J, Sui T, Yang R. DNMT3B 579G . T promoter polymorphism and the risk for idiopathic thrombocytopenic purpura in a Chinese population. Acta Haematol 2009;122: 31-35.
36. Zhu S, Zhang H, Tang Y, Liu P, Wang J. DNMT3B polymorphisms and cancer risk: a meta analysis of 24 case-control studies. Mol Biol Rep 2012;39: 4429-4437.